Níl an doiciméad seo ar fáil i do theanga féin. Roghnaítear teanga eile as na teangacha atá ar fáil.

 Innéacs 
 Ar ais 
 Ar aghaidh 
 Téacs iomlán 
Nós Imeachta : 2018/2775(RSP)
Céimeanna an doiciméid sa chruinniú iomlánach
Na doiciméid roghnaithe :

Téacsanna arna gcur síos :

O-000122/2018 (B8-0001/2019)

Díospóireachtaí :

PV 12/02/2019 - 24
CRE 12/02/2019 - 24

Vótaí :

Téacsanna arna nglacadh :


Minutes
Tuesday, 12 February 2019 - StrasbourgFinal edition

24. Use of cannabis for medicinal purposes (debate)
CRE

Question for oral answer (O-000122/2018) by Dubravka Šuica, Guillaume Balas, Urszula Krupa, Catherine Bearder, Estefanía Torres Martínez, Martin Häusling and Piernicola Pedicini, on behalf of the ENVI Committee, to the Commission: Use of cannabis for medicinal purposes (B8-0001/2019)

Dubravka Šuica moved the question.

Věra Jourová (Member of the Commission) answered the question.

The following spoke Peter Liese, on behalf of the PPE Group, Guillaume Balas, on behalf of the S&D Group, Urszula Krupa, on behalf of the ECR Group, and Luke Ming Flanagan, on behalf of the GUE/NGL Group.

The following spoke: Věra Jourová.

Motion for a resolution to wind up the debate tabled under Rule 128(5):

—   Dubravka Šuica, Guillaume Balas, Urszula Krupa, Catherine Bearder, Estefanía Torres Martínez, Martin Häusling and Piernicola Pedicini, on behalf of the ENVI Committee, on use of cannabis for medicinal purposes (2018/2775(RSP)) (B8-0071/2019).

The debate closed.

Vote: minutes of 13.2.2019, item 16.11.

An nuashonrú is déanaí: 12 Meitheamh 2019Fógra dlíthiúil